LicianPro

ALXO stock

Alx Oncology Holdings (ALXO) stock news · $207.2M cap

Alx Oncology Holdings (ALXO) is a biotechnology company listed on US.

This ALXO news page leads with what Alx Oncology Holdings filed — not a scraped headline mill.

No cached 8-K sentence for ALXO yet. We will not pad this page with generic market recap.

Latest reported ALXO revenue for 2022-12-31 was $0. Net income was -$123.5M. ALXO currently screens at market cap $207.2M.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the ALXO stock page; for the tape open the quote page.

ALXO stock news FAQ

What is ALXO's latest net income?

Latest cached Alx Oncology Holdings (ALXO) net income was -$123.5M. Statements: https://lician.com/financials/alxo

What is ALXO's market cap?

Alx Oncology Holdings (ALXO) market cap is $207.2M on the latest cached fundamentals snapshot.

What kind of company is ALXO?

Alx Oncology Holdings (ALXO) is a biotechnology company listed on US.

Where is ALXO stock news listed?

Cached stock news for Alx Oncology Holdings (ALXO) is listed at https://lician.com/news/alxo. Filings: https://lician.com/sec/alxo

Not investment advice.

Full ALXO analysis